VC gene therapy is a medical firm that offers research and development of gene therapy formulations for retinitis pigmentosa.
VC Gene Therapy has raised $637K in total funding. The most recent round was Seed. The last funding was announced in December 2024.
VC Gene Therapy's investors include Ritsumeikan Social Impact Fund.
VC Gene Therapy is headquartered in Kobe, Japan.
VC gene therapy is a medical firm that offers research and development of gene therapy formulations for retinitis pigmentosa.
VC Gene Therapy is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VC Gene Therapy — Funding & Investors." VCBacked, December 24, 2024, https://www.vcbacked.co/company/vc-gene-therapy. Accessed August 14, 2026.
VCBacked. (2024). VC Gene Therapy — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vc-gene-therapy
{{cite web |title=VC Gene Therapy — Funding & Investors |url=https://www.vcbacked.co/company/vc-gene-therapy |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated